We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

European Generic Makers Wary Of Marketing Exclusivity For Pediatric Testing

Law360 (April 20, 2005, 12:00 AM EDT) -- European generic drug makers have launched a campaign to amend European Union plans to offer six months of extended marketing exclusivity for drugs that undergo pediatric testing.

The European Generic Medicines Association, which represents the region’s generics makers, has acknowledged that some additional market exclusivity may be “acceptable” to offset costs of pediatric testing.

However, the trade group claims an automatic six-month extension for all pediatric testing would be a mistake, leading to higher drug costs for consumers while brand-name drug makers benefit unfairly from the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.